Enlitic (ASX:ENL) PS Ratio: 0.63 (As of Jul. 02, 2026) — 76% Below Median


What is Enlitic PS Ratio?

Enlitic ASX:ENL PS Ratio is 0.63 as of Jul. 02, 2026, which is 76% below its 10-year median of 2.68. The stock has 2 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Enlitic ranks better than 75.42% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Enlitic's share price is A$0.005. Enlitic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.01. Hence, Enlitic's PS Ratio for today is 0.63.

Good Sign:

Enlitic Inc stock PS Ratio (=0.63) is close to 1-year low of 0.63.

The historical rank and industry rank for Enlitic's PS Ratio or its related term are showing as below:

ASX:ENL' s PS Ratio Range Over the Past 10 Years
Min: 0.34   Med: 2.68   Max: 10.56
Current: 0.63

During the past 3 years, Enlitic's highest PS Ratio was 10.56. The lowest was 0.34. And the median was 2.68.

ASX:ENL's PS Ratio is ranked better than
75.42% of 659 companies
in the Healthcare Providers & Services industry
Industry Median: 1.5 vs ASX:ENL: 0.63

Enlitic's Revenue per Sharefor the six months ended in Dec. 2025 was A$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.01.

Warning Sign:

Enlitic Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Enlitic was -11.10% per year.

Back to Basics: PS Ratio


Enlitic  (ASX:ENL) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Enlitic PS Ratio Related Terms


Enlitic PS Ratio Historical Data

* Premium members only.

The historical data trend for Enlitic's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlitic PS Ratio Chart

Enlitic Annual Data
Trend Dec23 Dec24 Dec25
PS Ratio
5.55 6.67 2.25

Enlitic Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
PS Ratio 0.00 0.00 6.67 0.00 2.25

ASX:ENL vs VEEV, BTSG, TEM: PS Ratio Comparison

For the Health Information Services subindustry, Enlitic's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enlitic PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enlitic's PS Ratio distribution charts can be found below:

* The bar in red indicates where Enlitic's PS Ratio falls into.



Enlitic PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Enlitic's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.005/0.008
=0.63

Enlitic's Share Price of today is A$0.005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Enlitic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.63 mean?
Enlitic (ASX:ENL) has a PS Ratio of 0.63 as of Jul. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Enlitic and its competitors. This is 76% below median its historical median of 2.68. Over the past decade, Enlitic's PS Ratio has ranged from 0.34 to 10.56. According to the industry distribution chart, Enlitic ranks #162 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 24.6%.
Is Enlitic's PS Ratio too high?
Enlitic's current PS Ratio of 0.63 is 76% below median its 10-year median of 2.68. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 10.56. The Healthcare Providers & Services industry median PS Ratio is 1.50. Enlitic's value of 0.63 is 58% below this industry median. Based on the distribution chart, Enlitic ranks #162 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Enlitic's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Enlitic ranks #162 out of 659 companies for PS Ratio. This places Enlitic in the top 25% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.50. Enlitic's value of 0.63 is 58% below this benchmark. Historically, Enlitic's own PS Ratio has ranged from 0.34 to 10.56 over the past decade. While the company's 10-year median is 2.68 vs. the industry median of 1.50, Enlitic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Enlitic's current PS Ratio of 0.63 is 58% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Enlitic and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enlitic's current PS Ratio is 0.63, which is 76% below median its own 10-year median of 2.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlitic stock overvalued right now?
Enlitic (ASX:ENL) has a current PS Ratio of 0.63. The current PS Ratio is 0.63, which is 76% below median its 10-year median of 2.68 and 58% below the Healthcare Providers & Services industry median of 1.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Enlitic (ASX:ENL), the current PS Ratio is 0.63 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlitic Business Description

Address 1635 Foxtrail Drive, Suite 111A, Loveland, CO, USA, 80538
Enlitic Inc is the AI-enabled healthcare revolution. The company has developed an intelligent data framework that powers critical workflows, orchestrates data, and enables greater comprehension of what information resides in archives thereby unlocking new revenue opportunities, generating cost savings, and improving healthcare delivery. It provides solutions for Radiologists, IT Professionals, Executives, and Researchers. The Group has two operating segments: Software includes intelligently managing healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows, etc; and Migration services Transfer large volumes of imaging data to allow for the smooth transition of software solutions for healthcare vendors and providers and Migration services.